KANK4 and pancreatic acinar cell carcinoma: Although the majority of patients had progressive disease with this combination (51%), one patient with pancreatic acinar cell carcinoma with metastases to the liver and mesenteric lymph nodes whose tumor harbored a KANK4-RAF1 fusion identified by next generation sequencing achieved a partial response that encouragingly lasted for over 8 months.